Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
Category: Personalized Oncology
Synergistic interactions with PI3K inhibition that induce apoptosis
Synergistic interactions with PI3K inhibition that induce apoptosis
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development
First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression
Integrated genetic and pharmacologic interrogation of rare cancers
Integrated genetic and pharmacologic interrogation of rare cancers
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors